Is IRIX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IRIX. It does not provide personalized investment advice.

IRIX (Iridex Corp) Stock Analysis - Financials

Iridex Corp (IRIX) is a publicly traded Healthcare sector company. As of July 21, 2026, IRIX trades at $0.94 with a market cap of $16.26M and a P/E ratio of 0.00. IRIX moved +0.00% today. Year to date, IRIX is -19.51%; over the trailing twelve months it is -26.54%. Its 52-week range spans $0.78 to $1.95. Analyst consensus is buy with an average price target of $2.75. Rallies surfaces IRIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are IRIX's key financials?

IRIX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IRIX recently traded at $0.94. Market cap is $16.26M. P/E ratio is 0.00. Revenue is $0.

IRIX Key Metrics

Key financial metrics for IRIX
Metric	Value
Price	$0.94
Market Cap	$16.26M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$1.95
52-Week Low	$0.78
Volume	16.47K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

IRIX Analyst Consensus

1 analysts cover IRIX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.75.

Common questions about IRIX

What are IRIX's key financials?: IRIX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IRIX recently traded at $0.94. Market cap is $16.26M. P/E ratio is 0.00. Revenue is $0.
Is IRIX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IRIX. It does not provide personalized investment advice.